Skip to main content

CHIBEblog

Jun 27 2018
Love0

The Evidence on Health Behavior Incentives in State Medicaid Programs

By CHIBEblog

AcademyHealth Panel Rounds Up the Research As a number of states experiment with health incentives as an element of their Medicaid programs, researchers are analyzing the results with an eye towards informing future evidence-based policies. At this week’s AcademyHealth Annual Research Meeting, CHIBE affiliated faculty member Charlene Wong, MD led a panel in which investigators discussed the latest evidence on the impact of these incentives on healthy behaviors among Medicaid beneficiaries. The panel began with a presentation by Rob Saunders, PhD of the Duke Margolis Center for Health Policy. Saunders and his colleagues, including Dr. Wong, recently authored an issue…

Read More
Jun 22 2018
Love0
NEJM Catalyst logo

NEJM Catalyst: Moving from a Sickness Model of Health Care to One of Well-Being — Part 2

By CHIBEblog

Kevin Volpp, MD, PhD, interviews Karen DeSalvo, MD, MPH, Professor in the Departments of Internal Medicine and Population Health at Dell Medical School, and former Acting Assistant Secretary for Health in the U.S. Department of Health and Human Services. Part 2 of a 2-part interview. Missed part 1? Catch up here. Kevin Volpp:  One other area I want to ask you about is related to tools, specifically technology and digital health. You’ve done a lot of work in that space, and I’m curious what you see as particularly promising ways to leverage technology and digital health, and traditional public health programs and…

Read More
Jun 15 2018
Love0
NEJM Catalyst logo

NEJM Catalyst: Moving from a Sickness Model of Health Care to One of Well-Being — Part 1

By CHIBEblog

Kevin Volpp, MD, PhD, interviews Karen DeSalvo, MD, MPH, Professor in the Departments of Internal Medicine and Population Health at Dell Medical School, and former Acting Assistant Secretary for Health in the U.S. Department of Health and Human Services. Part 1 of a 2-part interview. Part 2 continues here. Kevin Volpp:  Hi, this is Kevin Volpp. I am a professor at the University of Pennsylvania, and I’m joined today by Karen DeSalvo. Karen is a professor at the Dell Medical School at UT Austin and has had a very distinguished public health career. I’m pleased to have Karen join me today,…

Read More
Jun 11 2018
Love0
way to health logo

Adapting Way to Health for Research on Depression

By CHIBEblog

Way to Health was purpose-built to help researchers address critical and complex problems facing healthcare and patient health by providing the tools needed to rigorously test solutions on one comprehensive digital platform. Mental illness qualifies as one of those challenges in need of fixing. It is estimated that 9.6 million American adults suffer from a serious mental illness (SMI), experiencing a diminished ability to function in daily life and a shorter life-expectancy. In addition to the patient burden, mental illness drains healthcare budgets as the third most expensive medical condition after heart conditions and traumatic injury. Way to Health will…

Read More
Jun 08 2018
Love0
man Damon stands in front of black board with a drawing on it

Research Finds Tipping Point (Hint: It’s 25%) For Large-Scale Social Change

By CHIBEblog

When organizations turn a blind eye to sexual harassment in the workplace, how many people need to take a stand before the behavior is no longer seen as normal? According to a new paper published to be published tomorrow in Science(link is external), there is a quantifiable answer: roughly 25% of people need to take a stand before large-scale social change occurs. This idea of a social tipping point applies to standards in the workplace, and any type of movement or initiative. Online, people develop norms about everything from what type of content is acceptable to post on social media, to how…

Read More
Jun 07 2018
Love0
Scott Halpern headshot

Smoking Cessation in the Workplace: What Works?

By CHIBEblog

My colleagues and I, including Kevin Volpp and Michael Harhay, recently published results of a large smoking cessation trial in the New England Journal of Medicine. We tested the real-world effectiveness of offering five strategies for quitting smoking among all known smokers at 54 U.S. companies (over 6,000 employees), regardless of their interest in quitting. The results reflect what employers, insurers, or others offering similar programs might expect to see. I want to share some thoughts on the trial, including what we can and cannot conclude, and answer some questions I’ve heard so far. Scott D. Halpern, MD, PhD, Associate Professor of Medicine, Epidemiology, and Medical Ethics…

Read More
Jun 05 2018
Love0

Balancing Affordability And Access: Lessons From New Cholesterol-Lowering Drugs

By CHIBEblog

A new class of cholesterol-lowering agents known as PCSK9 inhibitors (PCSK9Is) are back in the headlines for two seemingly contradictory reasons: the release of new clinical trial results showing that treatment with alirocumab (Praluent®), one of two PCSK9Is currently on the market, is indeed associated with favorable cardiovascular outcomes; and an announcement of unprecedented price reductions for the same drug as part of a new deal between the manufacturer and a large pharmacy benefit manager. Since when does more positive clinical evidence for a drug lead to lower prices? PCSK9Is offer a fascinating case study in the intersections between pharmaceutical innovation, specialty drug…

Read More
Close Menu